£57.27

This is the most expensive it has ever been. Walk away.

£57 today · previous high £57 · all-time low £56

Elsevier Alzheimer's Disease Theranostics

Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 38 days · 38 data points (no recent data)

Historical
Generating forecast…
£57.27 £55.82 £56.13 £56.45 £56.77 £57.09 £57.40 11 August 2026 20 August 2026 29 August 2026 07 September 2026 17 September 2026
View at Amazon ↗

Price data last checked 53 day(s) ago - refreshing...

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 38 days • 2 price levels

Days at Price
Current Price
13 days 25 days 0 6 13 19 25 £56 £57 Days at Price

Price Analysis

Most common price: £57 (25 days, 65.8%)

Price range: £56 - £57

Price levels: 2 different prices over 38 days

Description

Alzheimer’s Disease Theranostics discusses the latest information on recent theranostic avenues for both the diagnosis and treatment of Alzheimer’s patients. It presents the pros and cons of the probable mechanistic role of nanoparticles in crossing the blood-brain barrier and improving disease symptoms. Finally, it highlights the merits of existing maneuvers and suggests perspectives to aid in future developments. Despite the difficulty of drug delivery to the brain, there are some nanoparticulate platforms demonstrating promise in treating neurodegenerative disorders such as Alzheimer’s disease. Manifold theranostic maneuvers include antioxidants, natural bioactive compounds, gene therapy, and nanotechnological approaches, all of which are discussed in this important work. Examines various theranostic applications for the diagnosis and treatment of Alzheimer’s disease Features a comprehensive overview of nanoparticle therapeutics in the area and use of antioxidants Assesses the common challenges and lessons learned from blood-brain barrier challenges, viral vector approaches and mitochondria-targeted therapeutics

Product Specifications

Barcode

No barcode data available

Similar Products You Might Like

Nanoarchitectonics for Brain Drug Delivery (Advances in Bionanotechnology)
85% match

Nanoarchitectonics for Brain Drug Delivery (Advances in Bionanotechnology)

CRC Press

£61.46 15 Sep 2026
Cellular and Molecular Mechanisms in Alzheimer’s Disease Therapeutics: 2-volume set
84% match

Cellular and Molecular Mechanisms in Alzheimer’s Disease Therapeutics: 2-volume set

£274.84 04 Nov 2026
Immunotherapies for Neurological Disorders: Unlocking the Brain's Defenses
84% match

Immunotherapies for Neurological Disorders: Unlocking the Brain's Defenses

Elsevier

£137.99 21 Oct 2026
Global Clinical Trials for Alzheimer's Disease: Design, Implementation, and Standardization
84% match

Global Clinical Trials for Alzheimer's Disease: Design, Implementation, and Standardization

Elsevier

£60.06 16 Sep 2026
Alzheimer’s Disease: A Physician’s Guide to Practical Management (Current Clinical Neurology)
84% match

Alzheimer’s Disease: A Physician’s Guide to Practical Management (Current Clinical Neurology)

Humana

£74.21 23 Oct 2026
Handbook of Imaging the Alzheimer Brain (Advances in Alzheimer′s Disease (IOS Press))
82% match

Handbook of Imaging the Alzheimer Brain (Advances in Alzheimer′s Disease (IOS Press))

Sage Publishing

£143.41 13 Sep 2026
82% match

Epigenetics and miRNA in Neurodegenerative Diseases: From Molecular Mechanisms to Clinical Applications

Elsevier

£157.99 21 Oct 2026
Novel Therapeutic Approaches Targeting Oxidative Stress
82% match

Novel Therapeutic Approaches Targeting Oxidative Stress

Elsevier

£126.99 03 Nov 2026
Nanotechnology in Brain Tumor Treatment: Unveiling Molecular Mechanisms and Pioneering Therapies
82% match

Nanotechnology in Brain Tumor Treatment: Unveiling Molecular Mechanisms and Pioneering Therapies

Elsevier

£137.99 22 Oct 2026
Alzheimer Disease: Neuropsychology and Pharmacology
82% match

Alzheimer Disease: Neuropsychology and Pharmacology

Birkhauser

£85.41 03 Nov 2026
Biomarkers for Alzheimer’s Disease Drug Development: 1750 (Methods in Molecular Biology, 1750)
82% match

Biomarkers for Alzheimer’s Disease Drug Development: 1750 (Methods in Molecular Biology, 1750)

Humana

£58.50 22 Oct 2026
Nanostructures for Novel Therapy: Synthesis, Characterization and Applications (Micro and Nano Technologies) (Nanostructures in Therapeutic Medicine)
82% match

Nanostructures for Novel Therapy: Synthesis, Characterization and Applications (Micro and Nano Technologies) (Nanostructures in Therapeutic Medicine)

Elsevier

£139.89 16 Oct 2026
Alzheimer’s Turning Point: A Vascular Approach to Clinical Prevention
82% match

Alzheimer’s Turning Point: A Vascular Approach to Clinical Prevention

Springer

£50.87 17 Sep 2026
82% match

Building Blocks of Neuroimmunometabolism: From Molecular Pathways to Therapeutic Strategies

Elsevier

£157.99 21 Oct 2026
Advances in Plasma Physics Research: v. 2: Vol 2: Volume 2
81% match

Advances in Plasma Physics Research: v. 2: Vol 2: Volume 2

£58.23 01 Oct 2026
Pharmaceutical Nanobiotechnology for Targeted Therapy (Nanotechnology in the Life Sciences)
81% match

Pharmaceutical Nanobiotechnology for Targeted Therapy (Nanotechnology in the Life Sciences)

Springer

£104.02 15 Sep 2026
Current State of Alzheimer's Disease Research and Therapeutics
81% match

Current State of Alzheimer's Disease Research and Therapeutics

Academic Press

£155.00 22 Oct 2026
Current State of Alzheimer's Disease Research and Therapeutics: 64 (Advances in Pharmacology): Volume 64
81% match

Current State of Alzheimer's Disease Research and Therapeutics: 64 (Advances in Pharmacology): Volume 64

Elsevier

£125.00 16 Sep 2026
Research Progress in Alzheimer's Disease and Dementia: v. 3 (Nova Biomedical): Volume 3
81% match

Research Progress in Alzheimer's Disease and Dementia: v. 3 (Nova Biomedical): Volume 3

£112.13 24 Oct 2026
Genes, Environment and Alzheimer's Disease
81% match

Genes, Environment and Alzheimer's Disease

Elsevier

£61.89 17 Sep 2026
Neuroimaging Diagnosis for Alzheimer's Disease and Other Dementias
81% match

Neuroimaging Diagnosis for Alzheimer's Disease and Other Dementias

Springer

£66.03 21 Oct 2026
Nanotechnology in Cancer (Micro and Nano Technologies)
81% match

Nanotechnology in Cancer (Micro and Nano Technologies)

Elsevier

£97.99 29 Aug 2026
Nanomaterials for Clinical Applications: Case Studies in Nanomedicines (Micro and Nano Technologies)
81% match

Nanomaterials for Clinical Applications: Case Studies in Nanomedicines (Micro and Nano Technologies)

Elsevier

£128.35 04 Nov 2026
Multi-Class Classification of Alzheimer's/Dementia using Deep Learning: Advanced Deep Learning Techniques for Early Detection of Alzheimer's and Dementia via Multi-Class Classification
81% match

Multi-Class Classification of Alzheimer's/Dementia using Deep Learning: Advanced Deep Learning Techniques for Early Detection of Alzheimer's and Dementia via Multi-Class Classification

LAP Lambert Academic Publishing

£59.00 13 Sep 2026